Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hexiao Tang

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|May 30, 2025
Reply: Angiotensin system inhibitors deserve further evaluation in the neoadjuvant treatment of resectable esophageal adenocarcinomaEric Abston, Abraham Geller, Ashok Muniappan, et al.
Frontiers in Immunology|May 27, 2026
Lactylation-driven PDLIM1/PDAP1 axis remodels the inflammatory landscape of acute lung injury: mechanistic insights and precision interventionHexiao Tang, Congkuan Song, Guiomar Correia, et al.
Computers in Biology and Medicine|November 6, 2022
The mechanism and biomarker function of Cavin-2 in lung ischemia-reperfusion injuryHexiao Tang, Linao Sun, Jingyu Huang, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 21, 2025
Incidental use of angiotensin system inhibitors during neoadjuvant therapy for esophageal adenocarcinoma: An analysis of survivalAbraham Geller, Eric Abston, Ashok Muniappan, et al.
Scientific Reports|December 9, 2022
Hypoxia-associated prognostic markers and competing endogenous RNA coexpression networks in lung adenocarcinomaLecai Xiong, Xueyu He, Le Wang, et al.
Autoimmunity|July 20, 2018
Oestrogen receptor β5 and epidermal growth factor receptor synergistically promote lung cancer progressionYuquan Bai, Wulin Shen, Li Zhang, et al.
Future Oncology (London, England)|November 26, 2021
Optimum immunotherapy method according to PD-L1 expression in advanced lung cancer: a network meta-analysisLecai Xiong, Yi Cai, Xiao Zhou, et al.
Journal of Cellular Biochemistry|September 15, 2018
Combined detection of estrogen and tumor markers is an important reference factor in the diagnosis and prognosis of lung cancerYuquan Bai, Wulin Shen, Minglin Zhu, et al.
Current Gene Therapy|August 31, 2022
Mechanism of CAV and CAVIN Family Genes in Acute Lung Injury based on DeepGENEChangsheng Li, Hexiao Tang, Zetian Yang, et al.
Autoimmunity|June 6, 2018
Clinical significance of combined detection of interleukin-6 and tumour markers in lung cancerHexiao Tang, Yuquan Bai, Wulin Shen, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
The Journal of Thoracic and Cardiovascular Surgery|May 30, 2025
Reply: Angiotensin system inhibitors deserve further evaluation in the neoadjuvant treatment of resectable esophageal adenocarcinomaEric Abston, Abraham Geller, Ashok Muniappan, et al.
Frontiers in Immunology|May 27, 2026
Lactylation-driven PDLIM1/PDAP1 axis remodels the inflammatory landscape of acute lung injury: mechanistic insights and precision interventionHexiao Tang, Congkuan Song, Guiomar Correia, et al.
Computers in Biology and Medicine|November 6, 2022
The mechanism and biomarker function of Cavin-2 in lung ischemia-reperfusion injuryHexiao Tang, Linao Sun, Jingyu Huang, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 21, 2025
Incidental use of angiotensin system inhibitors during neoadjuvant therapy for esophageal adenocarcinoma: An analysis of survivalAbraham Geller, Eric Abston, Ashok Muniappan, et al.
Scientific Reports|December 9, 2022
Hypoxia-associated prognostic markers and competing endogenous RNA coexpression networks in lung adenocarcinomaLecai Xiong, Xueyu He, Le Wang, et al.
Autoimmunity|July 20, 2018
Oestrogen receptor β5 and epidermal growth factor receptor synergistically promote lung cancer progressionYuquan Bai, Wulin Shen, Li Zhang, et al.
Future Oncology (London, England)|November 26, 2021
Optimum immunotherapy method according to PD-L1 expression in advanced lung cancer: a network meta-analysisLecai Xiong, Yi Cai, Xiao Zhou, et al.
Journal of Cellular Biochemistry|September 15, 2018
Combined detection of estrogen and tumor markers is an important reference factor in the diagnosis and prognosis of lung cancerYuquan Bai, Wulin Shen, Minglin Zhu, et al.
Current Gene Therapy|August 31, 2022
Mechanism of CAV and CAVIN Family Genes in Acute Lung Injury based on DeepGENEChangsheng Li, Hexiao Tang, Zetian Yang, et al.
Autoimmunity|June 6, 2018
Clinical significance of combined detection of interleukin-6 and tumour markers in lung cancerHexiao Tang, Yuquan Bai, Wulin Shen, et al.
Pageof 4